Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carlyle Group Inc. stock logo
CG
Carlyle Group
$39.92
-0.8%
$46.18
$39.16
$67.46
$14.34B1.843.18 million shs2.60 million shs
K92 Mining Inc. stock logo
KNT
K92 Mining
C$29.26
-4.0%
C$27.17
C$15.94
C$33.45
C$7.49B1.980165784,208 shs753,563 shs
Rio Tinto PLC stock logo
RIO
Rio Tinto
$95.06
-2.5%
$98.55
$63.62
$112.58
$122.36B0.61.62 million shs2.66 million shs
10x Genomics stock logo
TXG
10x Genomics
$75.62
-6.3%
$59.11
$11.16
$82.68
$10.51B2.082.54 million shs3.47 million shs
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carlyle Group Inc. stock logo
CG
Carlyle Group
-1.54%-2.87%-18.51%-2.03%-40.65%
K92 Mining Inc. stock logo
KNT
K92 Mining
+4.78%+8.70%+0.89%+40.64%+78.41%
Rio Tinto PLC stock logo
RIO
Rio Tinto
+0.47%+0.26%-7.37%+3.81%+53.27%
10x Genomics stock logo
TXG
10x Genomics
+2.02%+8.48%+23.93%+133.38%+518.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carlyle Group Inc. stock logo
CG
Carlyle Group
$39.92
-0.8%
$46.18
$39.16
$67.46
$14.34B1.843.18 million shs2.60 million shs
K92 Mining Inc. stock logo
KNT
K92 Mining
C$29.26
-4.0%
C$27.17
C$15.94
C$33.45
C$7.49B1.980165784,208 shs753,563 shs
Rio Tinto PLC stock logo
RIO
Rio Tinto
$95.06
-2.5%
$98.55
$63.62
$112.58
$122.36B0.61.62 million shs2.66 million shs
10x Genomics stock logo
TXG
10x Genomics
$75.62
-6.3%
$59.11
$11.16
$82.68
$10.51B2.082.54 million shs3.47 million shs
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carlyle Group Inc. stock logo
CG
Carlyle Group
-1.54%-2.87%-18.51%-2.03%-40.65%
K92 Mining Inc. stock logo
KNT
K92 Mining
+4.78%+8.70%+0.89%+40.64%+78.41%
Rio Tinto PLC stock logo
RIO
Rio Tinto
+0.47%+0.26%-7.37%+3.81%+53.27%
10x Genomics stock logo
TXG
10x Genomics
+2.02%+8.48%+23.93%+133.38%+518.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carlyle Group Inc. stock logo
CG
Carlyle Group
2.40
Hold$59.3148.57% Upside
K92 Mining Inc. stock logo
KNT
K92 Mining
3.33
BuyC$37.2027.14% Upside
Rio Tinto PLC stock logo
RIO
Rio Tinto
2.38
Hold$103.138.49% Upside
10x Genomics stock logo
TXG
10x Genomics
2.24
Hold$44.00-41.81% Downside

Current Analyst Ratings Breakdown

Latest RIO, KNT, TXG, and CG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
10x Genomics stock logo
TXG
10x Genomics
Reiterated RatingSell (D-)
9/9/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
Boost Price TargetOutperform$88.50 ➝ $89.50
9/9/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageNeutral$20.00 ➝ $68.00
9/2/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
UpgradeStrong SellHold
9/1/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageSector Perform$70.00
9/1/2026
10x Genomics stock logo
TXG
10x Genomics
Initiated CoverageSector Perform$70.00
8/27/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
DowngradeBuyHold
8/24/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
Initiated CoverageOverweightUnderweight$90.00
8/20/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
UpgradeStrong-Buy
8/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetOverweight$50.00 ➝ $65.00
8/11/2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
UpgradeHold (C-)Hold (C)
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carlyle Group Inc. stock logo
CG
Carlyle Group
$4.78B2.98$5.10 per share7.82$19.58 per share2.04
K92 Mining Inc. stock logo
KNT
K92 Mining
C$795.83M9.03C$1.65 per share17.77C$3.97 per share7.37
Rio Tinto PLC stock logo
RIO
Rio Tinto
$57.64B2.07$13.62 per share6.98$53.43 per share1.78
10x Genomics stock logo
TXG
10x Genomics
$642.82M15.33N/AN/A$6.24 per share12.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carlyle Group Inc. stock logo
CG
Carlyle Group
$808.70M$0.9641.587.721.2810.08%22.52%5.62%11/6/2026 (Estimated)
K92 Mining Inc. stock logo
KNT
K92 Mining
C$53.92MC$1.4719.90N/AN/A45.48%43.29%7.49%N/A
Rio Tinto PLC stock logo
RIO
Rio Tinto
$9.97BN/AN/A10.891.18N/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.59N/AN/AN/A-12.18%-9.33%-7.30%11/5/2026 (Estimated)

Latest RIO, KNT, TXG, and CG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
K92 Mining Inc. stock logo
KNT
K92 Mining
N/AC$0.48N/AC$0.48N/AC$291.61 million
8/6/2026Q2 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.2431-$0.14+$0.1031-$0.14$146.67 million$151.04 million
8/4/2026Q2 2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
$0.9110$1.07+$0.1590$0.37$923.51 million$1.11 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Carlyle Group Inc. stock logo
CG
Carlyle Group
$1.403.51%+6.96%145.83%4 Years
K92 Mining Inc. stock logo
KNT
K92 Mining
N/AN/AN/AN/AN/A
Rio Tinto PLC stock logo
RIO
Rio Tinto
$4.184.40%-0.79%N/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest RIO, KNT, TXG, and CG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2026
Rio Tinto PLC stock logo
RIO
Rio Tinto
$2.114.41%8/14/20268/14/20269/24/2026
7/24/2026
Carlyle Group Inc. stock logo
CG
Carlyle Group
quarterly$0.352.88%8/17/20268/17/20268/26/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carlyle Group Inc. stock logo
CG
Carlyle Group
1.91
2.35
2.35
K92 Mining Inc. stock logo
KNT
K92 Mining
4.48
5.38
3.15
Rio Tinto PLC stock logo
RIO
Rio Tinto
0.29
1.42
0.93
10x Genomics stock logo
TXG
10x Genomics
N/A
5.69
5.25

Institutional Ownership

CompanyInstitutional Ownership
Carlyle Group Inc. stock logo
CG
Carlyle Group
55.88%
K92 Mining Inc. stock logo
KNT
K92 Mining
42.66%
Rio Tinto PLC stock logo
RIO
Rio Tinto
19.33%
10x Genomics stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Carlyle Group Inc. stock logo
CG
Carlyle Group
25.40%
K92 Mining Inc. stock logo
KNT
K92 Mining
2.53%
Rio Tinto PLC stock logo
RIO
Rio Tinto
N/A
10x Genomics stock logo
TXG
10x Genomics
8.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carlyle Group Inc. stock logo
CG
Carlyle Group
2,500356.33 million265.82 millionOptionable
K92 Mining Inc. stock logo
KNT
K92 Mining
N/A245.71 millionN/ANot Optionable
Rio Tinto PLC stock logo
RIO
Rio Tinto
61,0001.26 billionN/AOptionable
10x Genomics stock logo
TXG
10x Genomics
1,178130.29 million118.77 millionOptionable

Recent News About These Companies

3 Analysts, 3 Trades to Make Today
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
10x Genomics (NASDAQ:TXG) Given Consensus Rating of "Hold" by Brokerages
10x Genomics Inc Class A
UBS Sticks to Its Hold Rating for 10x Genomics (TXG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Carlyle Group stock logo

Carlyle Group NASDAQ:CG

$39.92 -0.31 (-0.77%)
Closing price 04:00 PM Eastern
Extended Trading
$40.01 +0.09 (+0.23%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).

K92 Mining stock logo

K92 Mining TSE:KNT

C$29.26 -1.23 (-4.03%)
As of 04:00 PM Eastern

K92 Mining Inc. is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine. The Company declared commercial production from Kainantu in February 2018, is in a strong financial position, and is working to become a Tier 1 mid-tier producer through ongoing expansions. A maiden resource estimate on the Blue Lake copper-gold porphyry project was completed in August 2022. K92 is operated by a team of mining company professionals with extensive international mine-building and operational experience.

Rio Tinto stock logo

Rio Tinto NYSE:RIO

$95.06 -2.43 (-2.49%)
Closing price 03:59 PM Eastern
Extended Trading
$95.71 +0.65 (+0.69%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. The Iron Ore segment engages in the iron ore mining, and salt and gypsum production in Western Australia. The Aluminum segment is involved in bauxite mining; alumina refining; and aluminium smelting. The Copper segment engages in mining and refining of copper, gold, silver, molybdenum, and other by-products and exploration activities. The Minerals segment is involved in mining and processing of borates, titanium dioxide feedstock, and iron concentrate and pellets; diamond mining, sorting, and marketing; and development projects for battery materials, such as lithium. It also owns and operates open pit and underground mines; and refineries, smelters, processing plants and power, and shipping facilities. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$75.62 -5.08 (-6.29%)
Closing price 04:00 PM Eastern
Extended Trading
$75.58 -0.04 (-0.05%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.